ArticleAmerican journal of cancer research2019

Serum CA125 and ascites leptin level ratio predicts baseline clinical resistance to first-line platinum-based treatment and poor prognosis in patients with high grade serous ovarian cancer.

Isabelle Matte et al.PubMed ↗Full text ↗

No numbers read from the abstract.